Drug Profile
Mexidol
Alternative Names: emoxipinLatest Information Update: 31 Oct 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antidementias; Anxiolytics; Neuroprotectants; Picolines; Small molecules
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Cognition disorders; Ischaemic heart disorders; Pancreatitis; Peptic ulcer
Most Recent Events
- 05 Dec 2000 A study has been added to the Peptic Ulcer Disease therapeutic trials section
- 04 Dec 2000 Investigation in Peptic ulcer in Russia (Unknown route)
- 04 Dec 2000 Preclinical development for Pancreatitis in Russia (Unknown route)